| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
2,111.90
|
|
Change (%)
|
-20.85 (-0.98%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
2,095.65
-
2,163.60
|
|
52-Week Range (RS)
|
1,228.00
-
2,649.95
|
|
Beta (1 Year)
|
0.52
|
|
|
|
|
|
| Index Details |
| BSE 500, BSE 200, BSE HC, BSE DOLLEX, BSE Midcap |
| News |
|
Corporate Details |
| Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Updates |
| Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Loss of Share Certificates |
| Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Loss of Share Certificates |
| Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Updates |
| Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Updates |
| GlaxoSmithKline Pharmaceuticals to declare Quarterly Result |
| Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Board Meeting |
| Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Loss of Share Certificates |
| Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Loss of Share Certificates |
| Glaxosmithkline Pharmaceuticals Ltd - GlaxoSmithKline Pharmaceuticals Limited - Other General Purpose |
|
|
|
| Incoporation Year : 1924 |
| Chairman : Renu S Karnad |
| Ownership Group : MNC Asc-Glaxo |
| Sector : MAN |
| Industry : Pharmaceuticals - Multinational |
| Registered Office |
Glaxosmithkline Pharmaceuticals Ltd
GSK House,
Dr Annie Besant Road Worli,
Mumbai,
Maharashtra-400030 |
Phone:91-022-24959595
Fax:91-022-24959494 |
| E-Mail : askus@gsk.com; ajay.a.nadkarni@gsk.com |
| URL : http://www.gsk-india.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
19-Apr-2024 |
1868.85 |
14.12 |
| 1Month |
26-Mar-2024 |
1924.50 |
10.82 |
| 3Month |
29-Jan-2024 |
2186.80 |
-2.47 |
| 6Month |
26-Oct-2023 |
1441.15 |
47.99 |
| 1Year |
26-Apr-2023 |
1234.25 |
72.80 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| Aditya Birla SL ELSS Tax Saver Fund |
1.52 |
227.14 |
| Nippon India Pharma Fund |
2.33 |
166.22 |
| SBI Magnum Midcap Fund |
0.93 |
157.07 |
| Kotak Equity Opportunities Fund |
0.65 |
129.78 |
| Quant Mid Cap Fund |
1.95 |
114.46 |
|
|
|
|
| Groups : Pharmaceuticals - Multinational |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Abbott India Ltd |
26,277.60 |
1.60 |
29,628.15 |
20,594.25 |
55,839.90 |
| Pfizer Ltd |
4,205.75 |
0.25 |
4,940.00 |
3,702.15 |
19,240.35 |
| Sanofi India Ltd |
8,282.05 |
0.05 |
9,370.35 |
5,329.70 |
19,073.56 |
| Astrazeneca Pharma India Ltd |
5,556.10 |
2.60 |
7,208.00 |
3,128.50 |
13,890.25 |
| Procter & Gamble Health Ltd |
4,774.40 |
1.06 |
5,640.00 |
4,595.85 |
7,925.50 |
|
|
|
|